1032349-98-6

Basic information

• Product Name: tert-butyl 1-(4-(2-phenylacetyl)phenyl)cyclobutylcarbaMate
• Synonyms: tert-butyl 1-(4-(2-phenylacetyl)phenyl)cyclobutylcarbaMate;Carbamic acid, N-[1-[4-(2-phenylacetyl)phenyl]cyclobutyl]-, 1,1-dimethylethyl ester;tert-Butyl [1-[4-(phenylacetyl)phenyl]cyclobutyl]carbamate
• CAS NO: 1032349-98-6
• Molecular Formula: C₂₃H₂₇NO₃
• Molecular Weight: 365.46538
• Mol File: 1032349-98-6.mol
• Article Data: 4

Chemical Properties

• Appearance: /
• CAS DataBase Reference: tert-butyl 1-(4-(2-phenylacetyl)phenyl)cyclobutylcarbaMate(CAS DataBase Reference)
• NIST Chemistry Reference: tert-butyl 1-(4-(2-phenylacetyl)phenyl)cyclobutylcarbaMate(1032349-98-6)
• EPA Substance Registry System: tert-butyl 1-(4-(2-phenylacetyl)phenyl)cyclobutylcarbaMate(1032349-98-6)

Safety Data

• Hazardous Substances Data: 1032349-98-6(Hazardous Substances Data)

Usage

General Description

Tert-butyl 1-(4-(2-phenylacetyl)phenyl)cyclobutylcarbamate is a chemical compound with a molecular formula of C25H27NO3. It is a carbamate derivative and is classified as a tert-butyl carbamate. tert-butyl 1-(4-(2-phenylacetyl)phenyl)cyclobutylcarbaMate is commonly used in organic synthesis and pharmaceutical research. It has been studied for its potential therapeutic applications, particularly as a potential drug candidate for the treatment of various medical conditions. Tert-butyl 1-(4-(2-phenylacetyl)phenyl)cyclobutylcarbamate is known for its structural complexity and has attracted interest in the scientific community for its potential biological activities and pharmacological properties.

Upstream product

• 50921-39-6 1-(4-chlorophenyl)cyclobutane-1-carboxylic acid 
• 24424-99-5 di-tert-butyl dicarbonate 
• 1032349-96-4 tert-butyl [1-(4-chlorophenyl)cyclobutyl]carbamate 
• 1032349-97-5 tert-butyl[1-(4-cyanophenyl)cyclobutyl]carbamate 
• 6921-34-2 benzylmagnesium chloride 

Downstream Products

• 1032349-99-7 tert-butyl {1-[4-(5-chloro-3-phenyl-1,6-naphthyrindin-2-yl)phenyl]cyclobutyl}carbamate 
• 1355998-33-2 2-(4-(1-aminocyclobutyl)phenyl)-3-phenylimidazo[1,2-a]pyridine-7-carboxamide 
• 1357159-07-9 tert-butyl 1-(4-(2-(2-formyl-1H-pyrrol-1-yl)-2-phenylacetyl)phenyl)cyclobutylcarbamate 
• 1357159-08-0 tert-butyl 1-(4-(4-phenylpyrrolo[1,2-a]pyrazin-3-yl)phenyl)cyclobutylcarbamate 
• 1357270-60-0 1-(4-(4-phenylpyrrolo[1,2-a]pyrazin-3-yl)phenyl)cyclobutanamine hydrochloride 
• 1402609-32-8 2-(4-{1-[(tert-butoxycarbonyl)amino]cyclobutyl}phenyl)-3-phenyl-imidazo[1,2-b]pyridazine-6-carboxylic acid 
• 1402609-33-9 methyl 2-(4-{1-[(tert-butoxycarbonyl)amino]cyclobutyl}phenyl)-3-phenyl-imidazo[1,2-b]pyridazine-6-carboxylate 
• 1402609-34-0 tert-butyl (1-{4-[6,8-bis(4-fluorophenyl)-3-phenylimidazo[1,2-b]pyridazin-2-yl]phenyl}cyclobutyl)carbamate 
• 1402609-35-1 tert-butyl {1-[4-(6-{4-[methoxy(methyl)carbamoyl]}-3-phenyl-imidazo[1,2-b]pyridazin-2-yl)phenyl]cyclobutyl}carbamate 
• 1402609-36-2 tert-butyl (1-{4-[6-(4-acetylphenyl)-3-phenylimidazo[1,2-b]pyridazin-2-yl]-phenyl}cyclobutyl)carbamate 
• 1402609-38-4 tert-butyl {1-[4-(6-chloro-7,8-dimethyl-3-phenylimidazo[1,2-b]pyridazin-2-yl)phenyl]cyclobutyl}carbamate 
• 1402609-41-9 tert-butyl {1-[4-(6-methoxy-7,8-dimethyl-3-phenylimidazo[1,2-b]-pyridazin-2-yl)phenyl]cyclobutyl}carbamate 
• 1402609-43-1 tert-butyl (1-{4-[7,8-dimethyl-6-(methylsulfanyl)-3-phenyl-imidazo[1,2-b]pyridazin-2-yl]phenyl}cyclobutyl)carbamate 
• 1402609-44-2 tert-butyl {1-[4-(6-ethoxy-7,8-dimethyl-3-phenylimidazo[1,2-b]-pyridazin-2-yl)phenyl]cyclobutyl}carbamate 

Relevant articles and documents

Diverse heterocyclic scaffolds as allosteric inhibitors of AKT

Wide-ranging exploration of potential replacements for a quinoline-based inhibitor of activation of AKT kinase led to number of alternative, novel scaffolds with potentially improved potency and physicochemical properties. Examples showed predictable DMPK properties, and one such compound demonstrated pharmacodynamic knockdown of phosphorylation of AKT and downstream biomarkers in vivo and inhibition of tumor growth in a breast cancer xenograft model.

INHIBITORS OF AKT ACTIVITY

The instant invention provides for substituted [1,2,4]triazolo[4,3-a]-1,5-naphthyridine compounds that inhibit Akt activity. In particular, the compounds disclosed selectively inhibit one or two of the Akt isoforms, preferably Akt1. The invention also pro